Daniela Paula Prudņikova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniela Paula Prudņikova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Agnese Brangule
Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, LV-1658 Riga, Latvia
2 shared publications - Ance Bārzdiņa
Department of Applied Pharmacy, Riga Stradins University, 21 Konsula Str., LV-1007 Riga, Latvia
2 shared publications - Dace Bandere
Department of Applied Pharmacy, Riga Stradins University, 21 Konsula Str., LV-1007 Riga, Latvia
2 shared publications - Renāte Šukele
Department of Applied Pharmacy, Riga Stradins University, 21 Konsula Str., LV-1007 Riga, Latvia
2 shared publications - Aiva Plotniece
Latvian Institute of Organic Synthesis
1 shared publication - Arkadij Sobolev
Latvian Institute of Organic Synthesis
1 shared publication
Latest Publications
- Open Access
- 11 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1463
Design of Experiments-Guided Development of Gallic Acid-Loaded Transethosomal Chitosan Gels
Background/Objectives: Gallic acid (GA) is a natural phenolic acid with reported antioxidant, anti-inflammatory, and antibacterial properties, but its limited skin permeation restricts its topical application. Although previous studies have demonstrated the potential of transethosomal formulations to enhance dermal GA delivery, their liquid dispersion form hinders practical topical use. Methods: The aim of this study was to investigate the effects of chitosan molecular weight, chitosan concentration, and transethosome proportion on the GA release, pH, and spreadability of GA-loaded transethosomal chitosan gel using a Design of Experiments (DoE)-guided approach. First, transethosomes were synthesized using the cold method and assessed for physicochemical properties, in vitro permeability, and physical stability. Next, transethosomal gels were prepared based on a three-level full factorial DoE model. The results were analyzed using polynomial regression modeling and sweet spot analysis. The model-predicted exploratory sweet-spot region was experimentally verified, followed by additional assessments of drug content and content uniformity, rheological properties, and short-term physical stability. Results: GA-loaded transethosomes had a diameter of 167.3 ± 9.9 nm, an encapsulation efficiency of 71.6 ± 5.7%, and substantially higher in vitro permeability across Strat-M® synthetic membranes (2520.77 ± 66.93 µg/cm2 within 24 h) compared to aqueous GA solution. After incorporation into chitosan gel, GA release at 6 h ranged from 65.5% to 93.2%. Formulations showed pH values of 3.93–4.46 and spreadability of 12.6–122.7 cm2. Increased chitosan concentration reduced GA release and increased pH toward the target range, while higher chitosan concentration and molecular weight restricted spreading. Rheological characterization revealed shear-thinning behavior. Conclusions: The DoE-guided approach supported exploratory screening of GA-loaded transethosomal chitosan gels and provided insights into the relationships between formulation composition, GA release, pH, and spreadability.
- 11 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1463
Open AccessDesign of Experiments-Guided Development of Gallic Acid-Loaded Transethosomal Chitosan Gels
Background/Objectives: Gallic acid (GA) is a natural phenolic acid with reported antioxidant, anti-inflammatory, and antibacterial properties, but its limited skin permeation restricts its topical application. Although previous studies have demonstrated the potential of transethosomal formulations to enhance dermal GA delivery, their liquid dispersion form hinders practical topical use. Methods: The aim of this study was to investigate the effects of chitosan molecular weight, chitosan concentration, and transethosome proportion on the GA release, pH, and spreadability of GA-loaded transethosomal chitosan gel using a Design of Experiments (DoE)-guided approach. First, transethosomes were synthesized using the cold method and assessed for physicochemical properties, in vitro permeability, and physical stability. Next, transethosomal gels were prepared based on a three-level full factorial DoE model. The results were analyzed using polynomial regression modeling and sweet spot analysis. The model-predicted exploratory sweet-spot region was experimentally verified, followed by additional assessments of drug content and content uniformity, rheological properties, and short-term physical stability. Results: GA-loaded transethosomes had a diameter of 167.3 ± 9.9 nm, an encapsulation efficiency of 71.6 ± 5.7%, and substantially higher in vitro permeability across Strat-M® synthetic membranes (2520.77 ± 66.93 µg/cm2 within 24 h) compared to aqueous GA solution. After incorporation into chitosan gel, GA release at 6 h ranged from 65.5% to 93.2%. Formulations showed pH values of 3.93–4.46 and spreadability of 12.6–122.7 cm2. Increased chitosan concentration reduced GA release and increased pH toward the target range, while higher chitosan concentration and molecular weight restricted spreading. Rheological characterization revealed shear-thinning behavior. Conclusions: The DoE-guided approach supported exploratory screening of GA-loaded transethosomal chitosan gels and provided insights into the relationships between formulation composition, GA release, pH, and spreadability.
- Open Access
- 4 August 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (8) , e0133626
Antibacterial and antibiofilm effects of natural phenolic acids: Insights into structure-function relationships, extracellular pH, and morphological changes
Wound infections are a challenging healthcare burden against which treatment is hindered by the presence of biofilms and the rise in antibacterial resistance. To date, the potential of natural phenolic acids as topical antibacterial agents is under-researched. The aim of this study was to investigate and compare the antibacterial and antibiofilm effects of 5 hydroxycinnamic acids (caffeic acid, chlorogenic acid, p -coumaric acid, ferulic acid, and rosmarinic acid), 4 hydroxybenzoic acids (gallic acid, salicylic acid, syringic acid, and vanillic acid), as well as 2 related compounds (tannic acid and quinic acid) against a panel of 10 bacterial strains. The tested phenolic acids showed a bactericidal action with minimum inhibitory concentration (MIC) values in the range of 0.625 to 10.0 mg/mL. A negative correlation between an increase in the polarity of the molecule and antibacterial effect was observed. At minimum bactericidal concentration (MBC), phenolic acids prevent an increase in extracellular pH by halting bacterial metabolism. Under bacterial metabolism-induced alkaline conditions, caffeic, chlorogenic, rosmarinic, and gallic acids change color to brown or green at sub-MIC concentrations. Caffeic and chlorogenic acids induce filamentation of planktonic P. aeruginosa . Tested phenolic compounds reduce biofilm biomass in the range of 10% to 90%, with Gram-positive biofilms being more susceptible. SEM imaging revealed a significantly diminished biofilm EPS with damaged cell structure after phenolic acid treatment. Out of the tested compounds, p -coumaric acid and salicylic acid show the most promise as antibacterial agents against bacterial species characteristic of wound infections. IMPORTANCE: The search for new antibacterial agents is one of the highest healthcare priorities. Phenolic acids are increasingly researched alone and as part of various drug delivery systems for wound care applications. However, to date, the available literature on the antibacterial effects of these compounds is rather fragmented and outdated, with unreproducible results. In this study, we link the physicochemical properties and structure of the molecules with their antibacterial and antibiofilm potential, investigate phenolic acid’s impact on the bacterial metabolism-induced extracellular pH change, and use SEM imaging to characterize the morphological changes of both planktonic bacteria and biofilms in response to phenolic acid treatment. Additionally, we provide an assessment of the compound ADMET properties with respect to their potential topical application. The data can be used in the future to test potential synergic effects with antibiotics, develop drug delivery systems, and investigate the efficacy of these agents against multi-resistant bacterial strains.
- 4 August 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (8) , e0133626
Open AccessAntibacterial and antibiofilm effects of natural phenolic acids: Insights into structure-function relationships, extracellular pH, and morphological changes
Wound infections are a challenging healthcare burden against which treatment is hindered by the presence of biofilms and the rise in antibacterial resistance. To date, the potential of natural phenolic acids as topical antibacterial agents is under-researched. The aim of this study was to investigate and compare the antibacterial and antibiofilm effects of 5 hydroxycinnamic acids (caffeic acid, chlorogenic acid, p -coumaric acid, ferulic acid, and rosmarinic acid), 4 hydroxybenzoic acids (gallic acid, salicylic acid, syringic acid, and vanillic acid), as well as 2 related compounds (tannic acid and quinic acid) against a panel of 10 bacterial strains. The tested phenolic acids showed a bactericidal action with minimum inhibitory concentration (MIC) values in the range of 0.625 to 10.0 mg/mL. A negative correlation between an increase in the polarity of the molecule and antibacterial effect was observed. At minimum bactericidal concentration (MBC), phenolic acids prevent an increase in extracellular pH by halting bacterial metabolism. Under bacterial metabolism-induced alkaline conditions, caffeic, chlorogenic, rosmarinic, and gallic acids change color to brown or green at sub-MIC concentrations. Caffeic and chlorogenic acids induce filamentation of planktonic P. aeruginosa . Tested phenolic compounds reduce biofilm biomass in the range of 10% to 90%, with Gram-positive biofilms being more susceptible. SEM imaging revealed a significantly diminished biofilm EPS with damaged cell structure after phenolic acid treatment. Out of the tested compounds, p -coumaric acid and salicylic acid show the most promise as antibacterial agents against bacterial species characteristic of wound infections. IMPORTANCE: The search for new antibacterial agents is one of the highest healthcare priorities. Phenolic acids are increasingly researched alone and as part of various drug delivery systems for wound care applications. However, to date, the available literature on the antibacterial effects of these compounds is rather fragmented and outdated, with unreproducible results. In this study, we link the physicochemical properties and structure of the molecules with their antibacterial and antibiofilm potential, investigate phenolic acid’s impact on the bacterial metabolism-induced extracellular pH change, and use SEM imaging to characterize the morphological changes of both planktonic bacteria and biofilms in response to phenolic acid treatment. Additionally, we provide an assessment of the compound ADMET properties with respect to their potential topical application. The data can be used in the future to test potential synergic effects with antibiotics, develop drug delivery systems, and investigate the efficacy of these agents against multi-resistant bacterial strains.